Genotype (GT) 3 has emerged as a difficultto- treat viral strain, achieving Sustained Virologic Response (SVR) rates lower than other genotypes. Data about GT3-infected HIV patients are scarce either from clinical trials or real life. Describe the outcome of GT3 co-infected individuals treated with DAA; explore factors associated with virological failure.

Genotype 3 Infection in HIV/HCV co-infected subjects in the DAA era: Real life data from the ICONA/HepaICONA Foundation cohorts

G. Nunnari;G. F. Pellicanò
2018-01-01

Abstract

Genotype (GT) 3 has emerged as a difficultto- treat viral strain, achieving Sustained Virologic Response (SVR) rates lower than other genotypes. Data about GT3-infected HIV patients are scarce either from clinical trials or real life. Describe the outcome of GT3 co-infected individuals treated with DAA; explore factors associated with virological failure.
2018
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3141769
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact